Laboratorios Farmaceuticos Rovi, S.A.
LABFFHealthcare · Stock · monthly payer
Forward Yield
23.77%
Annual Dividend
$21.54
Payout Ratio
0%
5-Yr Growth
—
Ex-Date
Jul 13, 2026
Frequency
Monthly
Summary
As of June 2026, Laboratorios Farmaceuticos Rovi, S.A. (LABFF) yields 23.77% ($21.54 per share annually), with a blended fair-value estimate of $89.89 — -1% downside, so it screens as fairly valued. Dividend safety grade: D (42/100).
Is LABFF a good dividend stock?
MixedLaboratorios Farmaceuticos Rovi, S.A. (LABFF) pays a monthly dividend yielding 23.77% ($21.54/yr), with 0 years of growth and a dividend-safety grade of D. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.
Advantages
Risks
- Cut its dividend in 2025
- Very high yield can signal elevated risk
- Below-average dividend safety score
Key Data
- Dividend Yield
- 23.77%
- Payout Ratio
- 0%
- Annual Dividend
- $21.54
- 5-Yr Avg Growth
- —
- Ex-Dividend Date
- Jul 13, 2026
- Years of Growth
- 0
- Frequency
- monthly
- Beta
- 0.22
- Market Cap
- $4.6B
- P/E Ratio
- 28.9
- 5-Yr Total Return
- 34%
- 52-Week Range
- $90.61 – $90.61
- Dividend Safety
- D · 42/100
- Ever Cut?
- Yes (2025)
Frequently Asked Questions
LABFF Price — Last 12 Months
Daily close
Price Return
1 Year
+0%
3 Years
+78%
5 Years
+34%
52-Week Range
$90.61 – $90.61
Price change over each period (excludes dividends). Past performance doesn't guarantee future results.
What is LABFF worth?
Fairly valuedmedium confidenceOur blended fair-value estimate for Laboratorios Farmaceuticos Rovi, S.A. is $89.89 per share, versus a market price of $90.61. That implies the stock is roughly fairly priced.
Fair Value
$89.89
Current Price
$90.61
Gap
-1%
Margin of Safety
-1%
How we get there
Discounted cash flow
Discounts projected free cash flow back to today.
Earnings multiple (Graham)
Graham's earnings-multiple formula, anchored to bond yields.
At today's price, the market is pricing in about 40.0% annual free-cash-flow growth. We model 20.0% — so the price already assumes faster growth than we think is likely.
Assumptions: 7.0% discount rate (CAPM), 20.0% stage-1 growth, 2.5% terminal growth, $3.13 EPS, $16.21 annual dividend. Updated weekly.
Fair-value estimates are model output for educational purposes only — not investment advice or a price target.
LABFF Dividend Safety Score
Risky
SmarterDividends' proprietary score, backtested against which dividends were actually cut over 15+ years (0.78 AUC). It blends a validated cut-risk model (growth streak, cut history) with current payout, cash-flow and debt. Higher is safer · not investment advice.
Dividend Growth
Total dividends per share by year
Dividend History
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| Jul 14, 2025 | — | $1.0890 | regular |
| Jul 14, 2025 | — | $1.0885 | regular |
| Jul 14, 2025 | — | $1.0856 | regular |
| Jul 14, 2025 | — | $1.0853 | regular |
| Jul 14, 2025 | — | $1.0835 | regular |
| Jul 14, 2025 | — | $1.0822 | regular |
| Jul 14, 2025 | — | $1.0820 | regular |
| Jul 14, 2025 | — | $1.0809 | regular |
| Jul 14, 2025 | — | $1.0802 | regular |
| Jul 14, 2025 | — | $1.0798 | regular |
| Jul 14, 2025 | — | $1.0782 | regular |
| Jul 14, 2025 | — | $1.0779 | regular |
| Jul 14, 2025 | — | $1.0772 | regular |
| Jul 14, 2025 | — | $1.0725 | regular |
Income Calculator
At $21.54 / yr per share
